Cargando…

KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function

Estrogen receptor alpha (ERα) is a ligand-activated nuclear receptor that directs proliferation and differentiation in selected cancer cell types including mammary-derived carcinomas. These master-regulatory functions of ERα require trans-acting elements such as the pioneer factor FOXA1 to establish...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gala, Kinisha, Li, Qing, Sinha, Amit, Razavi, Pedram, Dorso, Madeline, Sanchez-Vega, Francisco, Chung, Young Rock, Hendrickson, Ronald, Hsieh, James J., Berger, Michael, Schultz, Nikolaus, Pastore, Alessandro, Abdel-Wahab, Omar, Chandarlapaty, Sarat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107480/ https://www.ncbi.nlm.nih.gov/pubmed/29755131 http://dx.doi.org/10.1038/s41388-018-0273-5

Ejemplares similares

ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance
por: Strillacci, Antonio, et al.
Publicado: (2022)

ESR1 ligand binding domain mutations in hormone-resistant breast cancer
por: Toy, Weiyi, et al.
Publicado: (2013)

Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns
por: Mateo, Lidia, et al.
Publicado: (2020)

A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer
por: Dorso, M., et al.
Publicado: (2023)

Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer
por: Mayne, Christopher G., et al.
Publicado: (2021)

PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition
por: Castel, Pau, et al.
Publicado: (2016)

Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association
por: Tonsing-Carter, Eva, et al.
Publicado: (2019)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer
por: Smyth, Lillian M., et al.
Publicado: (2021)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Functions and physiological roles of two types of estrogen receptors, ERα and ERβ, identified by estrogen receptor knockout mouse
por: Lee, Hye-Rim, et al.
Publicado: (2012)

A role for estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) in collagen biosynthesis in mouse skin
por: Markiewicz, Margaret, et al.
Publicado: (2012)

Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1–KMT2A–YAP1 and VIM–KMT2A fusions
por: Massoth, Lucas R., et al.
Publicado: (2020)

mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation
por: Alayev, A, et al.
Publicado: (2015)

The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer
por: Hojnik, Marko, et al.
Publicado: (2023)

Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors
por: Dhar, Shilpa S., et al.
Publicado: (2021)

Association of KMT2C Genetic Variants with the Clinicopathologic Development of Oral Cancer
por: Shieu, Mu-Kuei, et al.
Publicado: (2022)

A tale of two estrogen receptors (ERs): how differential ER-estrogen responsive element interactions contribute to subtype-specific transcriptional responses
por: Huang, Jing, et al.
Publicado: (2006)

Transcriptomic analysis identifies gene networks regulated by estrogen receptor α (ERα) and ERβ that control distinct effects of different botanical estrogens
por: Gong, Ping, et al.
Publicado: (2014)

HER2 and ERβ2 downregulate estrogen-responsive element-mediated transcription activity of ERα-positive cells in response to estrogen stimulation
por: Park, B-W, et al.
Publicado: (2005)

Regulation of IL-20 Expression by Estradiol through KMT2B-Mediated Epigenetic Modification
por: Su, Chia-Hsin, et al.
Publicado: (2016)

KMT2A: Umbrella Gene for Multiple Diseases
por: Castiglioni, Silvia, et al.
Publicado: (2022)

KMT5B is required for early motor development
por: Hulen, Jason, et al.
Publicado: (2022)

Adult-onset KMT2B-related dystonia
por: Monfrini, Edoardo, et al.
Publicado: (2022)

The KMT2A recombinome of acute leukemias in 2023
por: Meyer, C., et al.
Publicado: (2023)

HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
por: Smith, Alison E., et al.
Publicado: (2021)

Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
por: Ferraro, Emanuela, et al.
Publicado: (2022)

Histone H1 variant-specific lysine methylation by G9a/KMT1C and Glp1/KMT1D
por: Weiss, Thomas, et al.
Publicado: (2010)

Pancreatic Insulin Content Regulation by the Estrogen Receptor ERα
por: Alonso-Magdalena, Paloma, et al.
Publicado: (2008)

Classical Estrogen Receptors and ERα Splice Variants in the Mouse
por: Irsik, Debra L., et al.
Publicado: (2013)

Xenoestrogens Alter Estrogen Receptor (ER) α Intracellular Levels
por: La Rosa, Piergiorgio, et al.
Publicado: (2014)

ERα expression in T lymphocytes is dispensable for estrogenic effects in bone
por: Gustafsson, K L, et al.
Publicado: (2018)

Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer
por: Shi, Liang, et al.
Publicado: (2015)

KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis
por: Lin-Shiao, Enrique, et al.
Publicado: (2018)

Optimal Strategy and Benefit of Pulsed Therapy Depend On Tumor Heterogeneity and Aggressiveness at Time of Treatment Initiation
por: Mathur, Deepti, et al.
Publicado: (2022)

Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role
por: Lloyd, Maxwell R., et al.
Publicado: (2022)

The Partial Duplication of the 5′ Segment of KMT2A Revealed KMT2A-MLLT10 Rearrangement in a Boy with Acute Myeloid Leukemia
por: Fukushima, Hiroko, et al.
Publicado: (2017)

Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis
por: Viswakarma, Navin, et al.
Publicado: (2017)

Dystonic Tremor in Adult-onset DYT-KMT2B
por: Shimazaki, Rui, et al.
Publicado: (2022)

Surgical Site Infections at Shirati KMT Hospital in Northeastern Tanzania
por: Bayardorj, Dulguun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e3bvrus32eg8eninqvh675jjmn